Back to funds
View filing
Samsara BioCapital, LLC
Updated 6 days agoManaged by Samsara Biocapital, Llc • Latest filing Q3 2026
Portfolio value
$1.1B
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 4 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q4 2025 | $969.3M |
| Q1 2026 | $1B |
| Q2 2026 | $1.2B |
| Q3 2026 | $1.1B |
Top holdings
27 positions as of Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | $333.3M | 6.90M | 31.69% | — | |
| 2 | $147.5M | 5.87M | 14.03% | — | |
| 3 | $120M | 3.07M | 11.41% | — | |
| 4 | $84.5M | 2.48M | 8.04% | — | |
| 5 | $54.9M | 2.11M | 5.22% | — | |
| 6 | $53.5M | 7.24M | 5.08% | — | |
| 7 | $51.9M | 1.87M | 4.94% | — | |
| 8 | ? N/A KALARIS THERAPEUTICS INC | $37.2M | 12.88M | 3.54% | — |
| 9 | $23.3M | 6.31M | 2.22% | — | |
| 10 | $18M | 556.0K | 1.71% | — | |
| 11 | ? N/A SUTRO BIOPHARMA INC | $17.1M | 1.06M | 1.63% | — |
| 12 | $12.1M | 7.24M | 1.15% | — | |
| 13 | $11.5M | 837.2K | 1.09% | — | |
| 14 | $11.3M | 2.43M | 1.07% | — | |
| 15 | $10.9M | 354.7K | 1.04% | — | |
| 16 | $10.3M | 736.2K | 0.98% | — | |
| 17 | $9.2M | 3.51M | 0.87% | — | |
| 18 | $8.2M | 10.37M | 0.78% | — | |
| 19 | $6.8M | 954.9K | 0.65% | — | |
| 20 | $6.6M | 594.7K | 0.63% | — |